IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 765
NA - Nord America 759
EU - Europa 737
SA - Sud America 119
AF - Africa 9
AN - Antartide 1
Totale 2.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 722
SG - Singapore 322
CN - Cina 278
RO - Romania 263
IT - Italia 137
SE - Svezia 114
BR - Brasile 103
DE - Germania 76
HK - Hong Kong 75
RU - Federazione Russa 29
CA - Canada 26
FI - Finlandia 25
GB - Regno Unito 25
VN - Vietnam 25
FR - Francia 19
IN - India 12
PL - Polonia 12
JP - Giappone 10
MX - Messico 9
NL - Olanda 9
AT - Austria 8
AR - Argentina 7
BD - Bangladesh 6
ID - Indonesia 6
IE - Irlanda 6
ZA - Sudafrica 6
LT - Lituania 5
PH - Filippine 5
TR - Turchia 5
IQ - Iraq 4
EG - Egitto 3
ES - Italia 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
CO - Colombia 2
IR - Iran 2
PK - Pakistan 2
PY - Paraguay 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IL - Israele 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
PE - Perù 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 2.390
Salva come PNG Salva come JPEG
Città #
Dallas 216
Singapore 166
Ashburn 94
Hong Kong 75
Shanghai 73
Beijing 57
Munich 47
Milan 37
Hefei 36
New York 33
Los Angeles 30
Lawrence 20
Princeton 20
Boardman 19
Helsinki 16
Rome 16
Moscow 15
Montreal 13
São Paulo 13
Atlanta 12
Warsaw 11
Ho Chi Minh City 10
Houston 9
Nuremberg 9
Orem 8
Toronto 8
Brooklyn 7
Cesano Boscone 7
Chicago 7
Amsterdam 6
London 6
Santa Clara 6
Tokyo 6
Turku 6
Denver 5
Frankfurt am Main 5
Guangzhou 5
Johannesburg 5
Shenzhen 5
Ancona 4
Ankara 4
Boston 4
Hanoi 4
Quezon City 4
Seattle 4
Stockholm 4
The Dalles 4
Baie-D'Urfé 3
Ballincollig 3
Chennai 3
Dublin 3
Falkenstein 3
Jundiaí 3
Manchester 3
New Delhi 3
Osimo 3
Poli 3
Poplar 3
Pune 3
Rio de Janeiro 3
Salvador 3
San Giuliano 3
Vittoria 3
York 3
Aobadai 2
Assago 2
Bauru 2
Belo Horizonte 2
Bexley 2
Bosco Chiesanuova 2
Brescia 2
Cairo 2
Campinas 2
Castel Mella 2
City of London 2
Concórdia 2
Council Bluffs 2
Dalmine 2
Diadema 2
Fermo 2
Florence 2
Ghent 2
Hangzhou 2
Honcho 2
Jakarta 2
Joinville 2
Kansas City 2
Lappeenranta 2
Mexico City 2
Milwaukee 2
Orlando 2
Phoenix 2
Pittsburgh 2
Rio Bonito 2
Roubaix 2
San Antonio 2
Tashkent 2
Turin 2
Venice 2
Verona 2
Totale 1.294
Salva come PNG Salva come JPEG
Nome #
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 325
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 147
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Biobanking for COVID-19 research 86
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 83
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 78
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 78
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 74
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 68
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 66
Drug retention rates of biological agents in adult onset Still's disease 65
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 64
Obesity and its role in the management of rheumatoid and psoriatic arthritis 64
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 62
COVID-19: Pharmacology and kinetics of viral clearance 62
Current treatment options and safety considerations when treating adult-onset Still’s disease 61
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 59
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 59
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 58
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 57
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 56
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 56
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 51
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 50
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 48
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 47
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 46
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 44
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 41
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 41
Low prevalence of arrhythmias in clinically stable COVID-19 patients 40
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 40
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 39
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 36
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 33
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 31
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 27
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease 22
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort 20
Totale 2.479
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 6 4 1 0 0 2 1
2021/202248 1 0 12 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025909 56 15 21 28 42 50 358 66 92 36 47 98
2025/20261.035 169 167 183 286 181 49 0 0 0 0 0 0
Totale 2.479